Exploiting the immune system to tackle emerging filamentous diseases in tomato
Exploiting the immune system to tackle emerging filamentous diseases in tomato
批准号:
BB/P00556X/1
负责人:
Estrella Luna Diez
金额:
$37.21万
依托单位:
依托单位国家:
英国
项目类别:
Fellowship
财政年份:
2017
资助国家:
英国
项目状态:
已结题
起止时间:
2017 至 --
中文摘要
点击翻译按钮获取中文摘要
英文摘要
The world's population is expected to increase by 1.6 billion in the next 40 years, which challenges humanity to increase food production by 70%. Despite current control measures, weeds, pests and pathogens claim up to 40% of our major crop yields after use of effective control. Filamentous pathogens (e.g. mildews, molds and late blight) are exceptionally problematic to control as their evolutionary capacity makes them highly proficient on overcoming the resistance offered by genes or chemical pesticides. In the past century, there has been an increasing number of virulent emerging pathogenic fungi. Agricultural systems are extremely vulnerable to emergence and epidemics of filamentous disease due to food mobility and climate change. Moreover, crop cultivation under controlled environment, even when it provides advantages in terms of increased production, it represents a clear disadvantage in controlling the spread of filamentous diseases. Current methods of control depend largely on the use of fungicides, which are under strict European regulation due to its toxicity to human health and the environment. Therefore, it is urgent to develop alternative strategies to control diseases. Plants are equipped to defend themselves against harmful microbes through constitutive and inducible defence strategies. Alternatively, plants have evolved the capacity to prepare their immune system to respond faster and stronger against attackers. This so-called priming of defence can be triggered by a variety of signals that warn of an upcoming attack, including treatments with priming agents such as b-amino butyric acid (BABA). BABA has been shown to provide protection against a wide spectrum of filamentous diseases. The reason for this outstanding performance is due to its priming activity at different defence signalling pathways that are used by plants to fight diseases with different lifestyles. BABA has been shown to be effective in inducing resistance against a broad-spectrum of diseases in crops such as tomato. Filamentous pathogens are particularly problematic in this crop as they are responsible for yield loses pre- and post-harvest. Therefore, emerging filamentous diseases are a serious threat to the tomato market.Tomato is a model plant for research in Solanaceae as its genome has been sequenced and crosses with their wild relatives allow the study of the genetics behind different processes. However, only one study in Arabidopsis has investigated genetic variation in the induced resistance response. This project will investigate genetic variation in induced resistance trigger by BABA in tomato with the overarching aim to identify advantageous traits which could potentially maximise the inducible resistance capacity of commercial varieties. To achieve this aim, I will test BABA-induced resistance against the devastating pathogen Phytophthora infestans (late blight) in a Recombinant Inbred Line (RIL) population from the cross between a commercial tomato cultivar, and an accession of the wild relative. Induced resistance quantification will be done by using a sophisticated phenotyping scanner that can image and analyse different disease parameters in a high-throughput manner. The induced resistance traits (IR-traits) will be identified by sequencing of the significant quantitative trait loci (QTLs) and the molecular mechanisms behind the response will be investigated. The last part of the project will test the hypothesis that multi-directional resistance as a result of the IR-traits offers effective protection against newly identified strains of filamentous pathogens with a high risk of emergence, such as strains of late blight or Fusarium wilt (caused by the multi-host pathogen Fusarium oxysporum). The results coming from this work will identify the genetic traits to exploit the tomato immune system for enhanced defence against a broad-spectrum of diseases, including emerging pathogens that can have a huge devastation potential.
期刊论文(9)
专著(0)
科研奖励(0)
会议论文
登录
查看更多内容
DOI:
10.3390/plants7040077
发表时间:
2018-09-21
期刊:
Plants (Basel, Switzerland)
影响因子:
--
作者:
[Pétriacq P, López A, Luna E]
通讯作者:
Luna E
Chitosan primes plant defence mechanisms against Botrytis cinerea , including expression of Avr9/Cf-9 rapidly-elicited genes
壳聚糖启动植物防御灰葡萄孢的机制,包括 Avr9/Cf-9 快速引发基因的表达
DOI:
10.1101/2020.04.01.019513
发表时间:
2020
期刊:
影响因子:
--
作者:
[De Vega D]
通讯作者:
De Vega D
DOI:
10.1111/pce.13921
发表时间:
2021-01
期刊:
Plant, cell & environment
影响因子:
--
作者:
[De Vega D, Holden N, Hedley PE, Morris J, Luna E, Newton A]
通讯作者:
Newton A
DOI:
10.1016/j.funbio.2019.04.006
发表时间:
2019-08-01
期刊:
FUNGAL BIOLOGY
影响因子:
2.5
作者:
[Kettles, Graeme J., Luna, Estrella]
通讯作者:
Luna, Estrella
MEMBRA: Understanding Memory of UK Treescapes for Better Resilience and Adaptation
-
批准号:NE/V021346/1
-
项目类别:Research Grant
-
资助金额:$231.83万
-
财政年份:2021
-
负责人:Estrella Luna Diez
-
依托单位:
Exploiting the immune system to tackle emerging filamentous diseases in tomato
-
批准号:BB/P00556X/2
-
项目类别:Fellowship
-
资助金额:$19.34万
-
财政年份:2018
-
负责人:Estrella Luna Diez
-
依托单位:
国内基金
海外基金
登录
查看更多内容
声致离子电流促进小胶质细胞M2极化阻断再生神经瘢痕退变免疫机制
-
批准号:82371973
-
项目类别:面上项目
-
资助金额:48.00万元
-
批准年份:2023
-
负责人:孙迪
-
依托单位:
转运蛋白RCP调控巨噬细胞脂肪酸氧化参与系统性红斑狼疮发病的机制研究
-
批准号:82371798
-
项目类别:面上项目
-
资助金额:49.00万元
-
批准年份:2023
-
负责人:叶俊娜
-
依托单位:
基于FCER1G基因介导免疫反应探讨迟发性聋与认知障碍相关性的机制研究
-
批准号:82371141
-
项目类别:面上项目
-
资助金额:49.00万元
-
批准年份:2023
-
负责人:陈颖
-
依托单位:
CD27-CD28-CD8+T细胞调控儿童肝脏移植免疫耐受形成的作用和机制
-
批准号:82371791
-
项目类别:面上项目
-
资助金额:49.00万元
-
批准年份:2023
-
负责人:刘永波
-
依托单位:
T细胞受体NRP1作为新型免疫检查点在去势抵抗性前列腺癌中的作用机制研究
-
批准号:32100631
-
项目类别:青年科学基金项目(C类)
-
资助金额:30.0万元
-
批准年份:2021
-
负责人:刘飞
-
依托单位:
抑制FGF19/FGFR4信号通路促进肺鳞癌细胞焦亡及免疫增效的机制研究
-
批准号:32100565
-
项目类别:青年科学基金项目(C类)
-
资助金额:30.0万元
-
批准年份:2021
-
负责人:李凡
-
依托单位:
自噬基因Epg5在诺如病毒感染过程中的作用
-
批准号:32070745
-
项目类别:面上项目
-
资助金额:58.0万元
-
批准年份:2020
-
负责人:路群
-
依托单位:
C9ORF72-SMCR8复合物在小胶质细胞中的功能及其介导的炎症反应
-
批准号:32070743
-
项目类别:面上项目
-
资助金额:58.0万元
-
批准年份:2020
-
负责人:杨玫
-
依托单位:
间充质干细胞通过CD73/CD39/腺苷-PI3K/Akt-Nrf2信号轴调节CD4+IL-10+IFN-γ+T细胞分化减弱GVHD机制研究
-
批准号:32070781
-
项目类别:面上项目
-
资助金额:58.0万元
-
批准年份:2020
-
负责人:栾希英
-
依托单位:
MET通过MTOR介导的自噬调节肝癌免疫原性和治疗抗性的作用及机制研究
-
批准号:31970696
-
项目类别:面上项目
-
资助金额:58.0万元
-
批准年份:2019
-
负责人:黄星
-
依托单位: